In a surprising twist to the Rs 6,000-crore Ponzi scheme perpetrated by Bhupendrasinh Zala, the police now estimate the BZ scam to be worth only Rs 450 crore. The police on Monday said Zala collected Rs 450 crore from 11,000 investors through 17 offices he set up across Gujarat between 2020 and 2024.
Zala, a resident of Himmatnagar town of Sabarkantha, was held from Mehsana district on December 27 after being on the run for almost a month. He is in police custody till January 4.
This story is from the December 31, 2024 edition of Ahmedabad Mirror.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the December 31, 2024 edition of Ahmedabad Mirror.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Blake Takes the Legal Pathway
Actress Files Federal Lawsuit Against Justin Baldoni, Others for Alleged Harassment and Smear Campaign
Kate speaks up about abuse
Actress says she was forced to do photoshoot the day after miscarriage
Ed hints at new album in 2025
Singer writes ‘2025 is a year of releasing, which I'm very excited about’ on his Gram post
Legal trouble follows Diljit into 2025
Faces legal action over 'pro-alcoholic' songs
Discovering the 'hero' within him
Sonu Sood explains the effect that Fateh has had on him
Hansal pulls up Naga Vamsi
Accuses Lucky Baskhar producer of 'borrowing liberally' from Scam series
The Year of 'Restart'
He's been on a hiatus for over a decade and now, Abhishek Jain - film director, producer and founder of CineMan Productions - is ready to hit the restart button with three films due for release this year and more. In a chat with Mirror, Jain talks about his upcoming work, the hiatus, et all
Vivek's investment tips go viral
Actor talks about creating an economic safety net, wealth creation in viral video
Kriti takes life inspo from Geet
The actress feels that there's a lot to pick from that film as life lessons.
Targeted therapies, diagnostics remain concern for severe asthma
There is an urgent need for improved diagnostic tools and targeted therapies to address the gap in care for patients with severe asthma, specifically for those with T-helper cell type 2 (T2)-low asthma, a subtype lacking typical inflammatory biomarkers, according to a recent report.
